For more than a century, HCPs have trusted Healio for clinical news, education, and insights. Today, Healio’s ecosystem connects with more than 3 million verified HCPs across 30 specialties, generating valuable first-party insights into the topics, treatments, and clinical advancements capturing their attention.

Unlike traditional data sources that tell marketers who an HCP is, Healio’s first-party behavioral data provides insight into what they’re actively interested in. By analyzing real engagement with clinical content, Healio helps brands identify HCPs based on demonstrated interests in specific disease states, therapies, and treatment developments, moving beyond assumptions to more meaningful audience targeting.

What makes Healio different isn’t just the quality of its data. It’s the ability to activate that intelligence across the digital ecosystem.

Healio transforms first-party behavioral insights into actionable HCP audiences that can be reached through programmatic, paid social, search, YouTube, connected TV, and digital audio. This allows pharmaceutical brands to connect with verified clinicians beyond Healio’s owned properties, delivering relevant messaging across the channels they engage with every day.